Interstitial Lung Disease News and Research

RSS

Interstitial lung disease (ILD) is a broad group of lung diseases comprising of more than a hundred distinct disorders. All of these involve scarring or inflammation of the interstitial lung tissue and affect the volume of oxygen that can reach the bloodstream via the respiratory system.

Blood biomarkers offer hope for early detection of interstitial lung disease

UVA Health lung researchers are developing a promising approach to detecting patients at risk of interstitial lung disease (ILD), an increasingly common condition that is a leading reason for lung transplants.

10 Oct 2025

Singing helps patients with COPD and interstitial lung disease

Singing can improve the quality of life of people with lung disease and help reduce their symptoms, according to a gold-standard randomzed-controlled trial presented at the European Respiratory Society Congress in Amsterdam, the Netherlands.

29 Sep 2025

electronRx to launch pDx app for remote chronic respiratory disease management

electronRx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it will launch pDx at HLTH 2025.

18 Sep 2025

Ifinatamab deruxtecan may benefit patients with recurrent or progressive ES-SCLC

Patients diagnosed with recurrent or progressive extensive-stage small cell lung cancer (ES-SCLC) may benefit from treatment with ifinatamab deruxtecan (I-DXd), a B7-H3–directed antibody–drug conjugate, according to data presented today at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC) in Barcelona, Spain.

8 Sep 2025

New guidelines for managing interstitial lung disease associated with connective tissue diseases

EULAR - The European Alliance of Associations for Rheumatology - has worked with the European Respiratory Society (ERS) to develop new clinical practice guidelines for interstitial lung disease (ILD) associated with connective tissue diseases (CTD).

5 Sep 2025

Targeting SRSF7 offers potential therapy for pulmonary fibrosis

This new article publication from Acta Pharmaceutica Sinica B, discusses how SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts.

10 Jul 2025

Immune cell signatures explain variations in systemic sclerosis severity

Treating rare diseases can be complicated at the best of times, and it gets even more complicated when different patients with the same disease exhibit different symptoms.

18 Jun 2025

Deep B cell depletion offers new hope for rheumatologic and musculoskeletal diseases

CD19-CAR T-cell treatment is a novel option of deep B cell depletion with promising results across different rheumatologic and musculoskeletal diseases (RMD).

15 Jun 2025

Early clinical events predict disease progression in very early systemic sclerosis

The VEDOSS project has previously shown that 70% of patients with Raynaud's phenomenon and at least one red flag – systemic sclerosis (SSc)-specific antibodies, puffy fingers, or an SSc pattern on nailfold capillaroscopy –will fulfil the 2013 ACR/EULAR SSc criteria within 5 years.

13 Jun 2025

KL-6 levels help differentiate interstitial lung disease from abnormalities

Krebs von den Lungen-6 (KL-6), predominantly expressed by type II alveolar cells, is linked to the prognosis and severity of interstitial lung disease (ILD).

10 May 2025

Comprehensive treatment approach helps patients manage rheumatoid arthritis

Although rheumatoid arthritis is an autoimmune disease with no cure, a tailored, multidisciplinary treatment approach at Cedars-Sinai's Inflammatory Arthritis Clinical Center helps patients get back to the activities they enjoy.

7 May 2025

Targeted drug zongertinib shows strong results for HER2-mutant lung cancer in clinical trial

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 mutations – with manageable side effects, according to results from the Phase Ia/Ib Beamion LUNG-1 trial led by researchers from The University of Texas MD Anderson Cancer Center.

28 Apr 2025

Breakthrough method allows stem cell treatment for critically ill patients on ECMO

A multidisciplinary clinical team led by Professor Bernat Soria from the Institute of Bioengineering at the Miguel Hernández University of Elche (UMH, Spain) has developed a new method to deliver cell therapies in patients on extracorporeal membrane oxygenation (ECMO), a life support system used in cases of severe lung failure.

16 Apr 2025

Advancing pulmonary fibrosis treatment through targeted drug delivery

Announcing a new article publication for BIO Integration journal. Pulmonary fibrosis (PF) is a progressive interstitial lung disease characterized by excessive extracellular matrix deposition and tissue scarring, and leading to impaired lung function and respiratory failure.

14 Apr 2025

Interstitial Lung Disease News and Research

Further Reading

Blood biomarkers offer hope for early detection of interstitial lung disease

Singing helps patients with COPD and interstitial lung disease

electronRx to launch pDx app for remote chronic respiratory disease management

Ifinatamab deruxtecan may benefit patients with recurrent or progressive ES-SCLC

New guidelines for managing interstitial lung disease associated with connective tissue diseases

Targeting SRSF7 offers potential therapy for pulmonary fibrosis

Immune cell signatures explain variations in systemic sclerosis severity

Deep B cell depletion offers new hope for rheumatologic and musculoskeletal diseases

Early clinical events predict disease progression in very early systemic sclerosis

KL-6 levels help differentiate interstitial lung disease from abnormalities

Comprehensive treatment approach helps patients manage rheumatoid arthritis

Targeted drug zongertinib shows strong results for HER2-mutant lung cancer in clinical trial

Breakthrough method allows stem cell treatment for critically ill patients on ECMO

Advancing pulmonary fibrosis treatment through targeted drug delivery

Exophiala pneumonia identified in immunocompetent woman with lung disease

Breakthrough protein offers new hope for pulmonary sarcoidosis treatment

Targeted rehab exercises improve lung health and mobility in long COVID patients

COVID-19 discovery could open the door to new treatments for chronic lung diseases

New gene therapy strategy could cure COPA Syndrome

USF study: Pulmonary fibrosis after COVID-19 tends to get better

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News